Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.34 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.34 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ALPI | P09923 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | XIAP | P98170 | 1/20 | 0.33 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 1/20 | 0.32 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL15956069 | 0.92 | SIGMAR1 (0.44) | TMEM97SIGMAR1MEN1KMT2ALMNA | |
| 3-Methylbutanoic Acid SCHEMBL15956110 | 0.89 | TMEM97 (0.39) | TMEM97SIGMAR1MEN1KMT2ALMNA | |
| Propionic Acid SCHEMBL15955794 | 0.88 | TMEM97 (0.41) | TMEM97SIGMAR1MEN1KMT2ALMNA | |
| Butyric Acid SCHEMBL15955929 | 0.85 | MEN1 (0.40) | TMEM97SIGMAR1MEN1KMT2ALMNA | |
| Valeric Acid SCHEMBL15956332 | 0.83 | TMEM97 (0.38) | TMEM97SIGMAR1MEN1KMT2ALMNA | |
| SCHEMBL15955851 | 0.82 | TMEM97 (0.39) | TMEM97SIGMAR1MEN1KMT2ALMNA | |
| SCHEMBL15955750 | 0.78 | CTDSP1 (0.32) | — | |
| SCHEMBL15956068 | 0.78 | ALDH1A1 (0.43) | TMEM97SIGMAR1MEN1KMT2ALMNA | |
| SCHEMBL15956109 | 0.77 | MGLL (0.42) | TMEM97SIGMAR1 | |
| SCHEMBL15218248 | 0.77 | MEN1 (0.40) | TMEM97SIGMAR1MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10239116-B2 | Solvent system and compositions therewith | RHODIA POLIAMIDA E ESPECIALIDADES LTDA (BR) | 2019-03-26 | — | — | US | disclosed |
| EP-2956513-B1 | SOLVENT SYSTEM AND COMPOSITIONS THEREWITH | RHODIA POLIAMIDA E ESPECIALIDADES LTDA (BR) | 2017-09-27 | — | — | EP | disclosed |
| EP-2956513-A1 | SOLVENT SYSTEM AND COMPOSITIONS THEREWITH | Rhodia Poliamida E Especialidades Ltda (BR) | 2015-12-23 | — | — | EP | disclosed |
| US-20150361281-A1 | SOLVENT SYSTEM AND COMPOSITIONS THEREWITH | RHODIA POLIAMIDA E ESPECIALIDADES LTDA (BR) | 2015-12-17 | — | — | US | disclosed |
| WO-2014125357-A1 | SOLVENT SYSTEM AND COMPOSITIONS THEREWITH | RHODIA POLIAMIDA E ESPECIALIDADES LTDA (BR) | 2014-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150361281-A1 | SOLVENT SYSTEM AND COMPOSITIONS THEREWITH | DECR1, SQLE, DECR2 | TMEM97 993/4885SIGMAR1 272/4885MEN1 1623/4885 |
| US-10239116-B2 | Solvent system and compositions therewith | DECR1, SQLE, DECR2 | TMEM97 993/4885SIGMAR1 272/4885MEN1 1623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.